Logo image of ATMCR

ALPHATIME ACQUISITION-RIGHT (ATMCR) Stock Overview

NASDAQ:ATMCR - KYG0223V1398

0.238 USD
-0.03 (-11.09%)
Last: 8/27/2025, 4:30:01 PM
Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to ATMCR. ATMCR was compared to 0 industry peers in the Unkown industry. ATMCR may be in some trouble as it scores bad on both profitability and health. ATMCR does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year ATMCR was profitable.
ATMCR had a positive operating cash flow in the past year.
ATMCR Yearly Net Income VS EBIT VS OCF VS FCFATMCR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 1M -1M

1.2 Ratios

Industry RankSector Rank
ROA 7.49%
ROE 12.2%
ROIC N/A
ROA(3y)4.1%
ROA(5y)N/A
ROE(3y)4.42%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ATMCR Yearly ROA, ROE, ROICATMCR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 -20 -40

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for ATMCR so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ATMCR Yearly Profit, Operating, Gross MarginsATMCR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024

More info and screens

1

2. Health

2.1 Basic Checks

The number of shares outstanding for ATMCR has been reduced compared to 1 year ago.
Compared to 1 year ago, ATMCR has a worse debt to assets ratio.
ATMCR Yearly Shares OutstandingATMCR Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 2M 4M 6M 8M
ATMCR Yearly Total Debt VS Total AssetsATMCR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

Based on the Altman-Z score of -0.96, we must say that ATMCR is in the distress zone and has some risk of bankruptcy.
The Debt to FCF ratio of ATMCR is 28.43, which is on the high side as it means it would take ATMCR, 28.43 years of fcf income to pay off all of its debts.
A Debt/Equity ratio of 0.13 indicates that ATMCR is not too dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.13
Debt/FCF 28.43
Altman-Z -0.96
ROIC/WACCN/A
WACCN/A
ATMCR Yearly LT Debt VS Equity VS FCFATMCR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 20M 40M 60M

2.3 Liquidity

ATMCR has a Current Ratio of 0.02. This is a bad value and indicates that ATMCR is not financially healthy enough and could expect problems in meeting its short term obligations.
A Quick Ratio of 0.02 indicates that ATMCR may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 0.02
Quick Ratio 0.02
ATMCR Yearly Current Assets VS Current LiabilitesATMCR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 1M 2M 3M

More info and screens

0

3. Growth

3.1 Past

ATMCR shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -14.20%.
EPS 1Y (TTM)-14.2%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-46.62%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

ATMCR is valuated cheaply with a Price/Earnings ratio of 1.25.
When comparing the Price/Earnings ratio of ATMCR to the average of the S&P500 Index (27.14), we can say ATMCR is valued rather cheaply.
Industry RankSector Rank
PE 1.25
Fwd PE N/A
ATMCR Price Earnings VS Forward Price EarningsATMCR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF 18.6
EV/EBITDA N/A
ATMCR Per share dataATMCR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.5 1 1.5 2 2.5

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ATMCR!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ALPHATIME ACQUISITION-RIGHT

NASDAQ:ATMCR (8/27/2025, 4:30:01 PM)

0.238

-0.03 (-11.09%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)04-15 2025-04-15
Earnings (Next)11-17 2025-11-17
Inst Owners52.06%
Inst Owner Change-3%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap825.86K
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 1.25
Fwd PE N/A
P/S N/A
P/FCF 18.6
P/OCF 18.6
P/B 0.09
P/tB 0.09
EV/EBITDA N/A
EPS(TTM)0.19
EY79.83%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.01
FCFY5.38%
OCF(TTM)0.01
OCFY5.38%
SpS0
BVpS2.77
TBVpS2.77
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 7.49%
ROE 12.2%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)4.1%
ROA(5y)N/A
ROE(3y)4.42%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score7
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.13
Debt/FCF 28.43
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 3.78%
Current Ratio 0.02
Quick Ratio 0.02
Altman-Z -0.96
F-Score7
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-14.2%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-46.62%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y15.47%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y119.3%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y119.3%
OCF growth 3YN/A
OCF growth 5YN/A